1. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma 
Jörg Zehetner, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen, MD, Shahin Ayazi, MD, Florian Augustin, MD, John C. Lipham, MD, Tom R. DeMeester, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 141, Issue 1, Pages (January 2011)
DOI: /j.jtcvs
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
A, Flow chart for the 18 patients with intramucosal cancer. B, Flow chart for the 22 patients with high-grade dysplasia. ER, Endoscopic resection; RFA, radiofrequency ablation; IM, intestinal metaplasia; HGD, high-grade dysplasia; IMC, intramucosal cancer.
The Journal of Thoracic and Cardiovascular Surgery  , 39-47DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Length of Barrett's segment before endoscopic therapy, number of treatment sessions, and pathology at the time of most recent endoscopy and biopsy. IM, intestinal metaplasia.
The Journal of Thoracic and Cardiovascular Surgery  , 39-47DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

4. Figure 3
Kaplan–Meier curve of overall survival for endoscopic therapy (ET) and esophagectomy (ESO).
The Journal of Thoracic and Cardiovascular Surgery  , 39-47DOI: ( /j.jtcvs )
Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions